For research use only
| Cat No. | ABC-X0343C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Fibroblast |
| Species | Human |
| Host Cell | NIH/3T3 |
| Source Organ | Embryo |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human EML4_ALK (C1156Y_G1296A) NIH/3T3 Cell Line enables assessment of resistance mutations to ALK inhibitors and their effect on cell signaling.
Human EML4_ALK (C1156Y_G1296A) NIH/3T3 Overexpression Cell Line is an engineered NIH/3T3 model harboring dual EML4-ALK mutations (C1156Y and G1296A) introduced via lentiviral transduction. Expression is confirmed by qRT-PCR, and cells are cultured below passage 20.
Target
C1156Y and G1296A are compound ALK mutations that confer broad resistance to ALK inhibitors, complicating targeted therapy for ALK-rearranged lung cancers. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0343C |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Embryo |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | NIH/3T3 |
For research use only